TR200200467T2 - Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. - Google Patents

Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Info

Publication number
TR200200467T2
TR200200467T2 TR2002/00467T TR200200467T TR200200467T2 TR 200200467 T2 TR200200467 T2 TR 200200467T2 TR 2002/00467 T TR2002/00467 T TR 2002/00467T TR 200200467 T TR200200467 T TR 200200467T TR 200200467 T2 TR200200467 T2 TR 200200467T2
Authority
TR
Turkey
Prior art keywords
delivery system
drug delivery
oral drug
stomach
hydrodynamic balancing
Prior art date
Application number
TR2002/00467T
Other languages
English (en)
Inventor
Talwar Naresh
N. Staniforth John
J. Tobyn Michael
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of TR200200467T2 publication Critical patent/TR200200467T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus, en az bir ilaç maddesi, seker(ler), gaz olusturma bilesenleri ve istege bagli olarak farmasötik açidan kabul edilebilir yardimci bilesenlerden olusan oldukça gözenekli bir matris içeren, midede tutulan oral ilaç verme sistemi ile ilgilidir. Topaklar (çok partikülatli veya tek üniteli dozaj formu), taneler, granüller veya kapsüller formundaki farmasötik kompozisyon midede tutulurken ilaç(lar) uzun bir süre zarfinda ince bagirsagin üst kisimlarinda ve mide seviyelerinde seçici olarak birakilir.
TR2002/00467T 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. TR200200467T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
TR200200467T2 true TR200200467T2 (tr) 2002-08-21

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00467T TR200200467T2 (tr) 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Country Status (21)

Country Link
EP (1) EP1206249A4 (tr)
JP (1) JP2003506400A (tr)
CN (1) CN1376059A (tr)
AP (1) AP2002002410A0 (tr)
AU (2) AU5060499A (tr)
BR (1) BR0012981A (tr)
CA (1) CA2378468A1 (tr)
CZ (1) CZ2002415A3 (tr)
EA (1) EA200200126A1 (tr)
HK (1) HK1047226A1 (tr)
HR (1) HRP20020108A2 (tr)
HU (1) HUP0202497A3 (tr)
IL (1) IL147966A0 (tr)
MX (1) MXPA02001272A (tr)
NZ (1) NZ516959A (tr)
OA (1) OA12003A (tr)
PL (1) PL353321A1 (tr)
SK (1) SK1832002A3 (tr)
TR (1) TR200200467T2 (tr)
WO (2) WO2001010405A1 (tr)
ZA (1) ZA200200926B (tr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
BR0211317A (pt) 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
CA2466032A1 (en) * 2001-10-29 2003-05-08 Laure Patricia Ouadji Njiki Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
CA2536906A1 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
RU2385724C2 (ru) * 2004-06-28 2010-04-10 Солвей Фармасьютикалс Б.В. Пероральная композиция тедисамила с замедленным высвобождением, обладающая свойством задержки в желудке
ME01316B (me) 2004-08-13 2013-12-20 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koji sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
AU2006330526B2 (en) 2005-12-22 2012-09-27 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
CA2678367C (en) 2007-03-02 2014-07-08 Farnam Companies, Inc. Sustained release compositions using wax-like materials
ES2740360T3 (es) 2008-08-15 2020-02-05 Assertio Therapeutics Inc Composiciones farmacéuticas de retención gástrica para el tratamiento y la prevención de trastornos del SNC
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
BRPI0914080A2 (pt) 2008-10-08 2015-10-27 Bioplus Life Sciences Pvt Ltda "sistema de liberação de dosagem controlada, método de administração e processo de preparação do mesmo"
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
ES2761407T3 (es) * 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación rápidamente dispersable de topiramato
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
DK3609472T3 (da) 2018-06-18 2021-04-06 Kashiv Specialty Pharmaceuticals Llc Forlænget frigivelsessammensætning indeholdende pyridostigmin
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
EP3968980A1 (en) 2019-05-14 2022-03-23 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (tr) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
HK1047226A1 (zh) 2003-02-14
WO2001010419A1 (en) 2001-02-15
HRP20020108A2 (en) 2003-12-31
EP1206249A1 (en) 2002-05-22
OA12003A (en) 2006-04-18
IL147966A0 (en) 2002-09-12
CN1376059A (zh) 2002-10-23
PL353321A1 (en) 2003-11-17
SK1832002A3 (en) 2002-08-06
HUP0202497A3 (en) 2004-05-28
JP2003506400A (ja) 2003-02-18
EA200200126A1 (ru) 2002-10-31
ZA200200926B (en) 2002-11-27
AU774957B2 (en) 2004-07-15
CZ2002415A3 (cs) 2002-08-14
CA2378468A1 (en) 2001-02-15
BR0012981A (pt) 2002-06-18
NZ516959A (en) 2003-10-31
AU6309900A (en) 2001-03-05
EP1206249A4 (en) 2004-12-22
AP2002002410A0 (en) 2002-03-31
MXPA02001272A (es) 2002-07-22
HUP0202497A2 (hu) 2002-11-28
AU5060499A (en) 2001-03-05
WO2001010405A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
HK1047226A1 (zh) 流体力学平衡口服药输送系统
IL150568A0 (en) A controlled release oral drug dosage form
NO923590D0 (no) Doseringsform for avgivelse av medikament til tarmen
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
ES2284643T3 (es) Composicion de revestimiento enmascarante del sabor.
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
ATE213629T1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
CA2112679A1 (en) Dosage form for delivering drug in short-time period
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
NO974404D0 (no) Insufflasjonsbærer for medikamenter med kontrollert frigivelse
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
DK0932388T3 (da) Doseringsform og fremgangsmåde til indgivelse af lægemidler
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
DE69940674D1 (de) Orale verabreichung von adenosin analogen
EP1595538A3 (en) Modified release tamsulosin tablets
EP1365749A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
KR900015724A (ko) 메베버린 용량 형태
BR0212155A (pt) Composição farmacêutica
HUP0104476A2 (hu) Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
MY100780A (en) Azumolene dosage form.
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles